SCHEMBL6950279

SCHEMBL6950279

CC(C)CCNC(=O)C(=O)OC1CCCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.58
RAB9A P51151 2/20 0.58
GAA P10253 1/20 0.58
MMP2 P08253 1/20 0.44
MMP8 P22894 1/20 0.44
ALDH1A1 P00352 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
EPHX1 P07099 3/20 0.44
ANPEP P15144 3/20 0.41
RNPEP Q9H4A4 3/20 0.41
DNPEP Q9ULA0 2/20 0.41
NPC1 O15118 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HSD17B10 Q99714 1/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CAPN9 O14815 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24539765 0.80 EPHX1 (0.54) SMN1; SMN2RAB9AGAAMMP2MMP8
SCHEMBL29980822 0.76 EPHX1 (0.68) SMN1; SMN2ALDH1A1CYP2C19EPHX1GPR35
SCHEMBL26157371 0.73 EPHX1 (0.58) SMN1; SMN2RAB9AGAAMMP2MMP8
SCHEMBL16363611 0.73 EPHX1 (0.54) SMN1; SMN2RAB9AGAAMMP2MMP8
SCHEMBL21786685 0.73 EPHX1 (0.46) SMN1; SMN2RAB9AGAAMMP2MMP8
SCHEMBL7199940 0.71 TSHR (0.44) RAB9AMMP2ALDH1A1CYP2C19EPHX1
SCHEMBL5158628 0.71 NAAA (0.41) SMN1; SMN2RAB9AGAAMMP2MMP8
SCHEMBL24539766 0.71 EPHX1 (0.51) SMN1; SMN2RAB9AGAAMMP2MMP8
SCHEMBL19429723 0.71 EPHX1 (0.44) SMN1; SMN2RAB9AGAAMMP2MMP8
SCHEMBL6385930 0.70 HSD17B10 (0.62) SMN1; SMN2RAB9AGAAMMP2MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268433-A1 CYCLIC LACTAMS AS INHIBITORS OF A-BETA-PROTEIN PRODUCTION Bristol-Myers Squibb Pharma Company (US) 2003-01-02 EP disclosed
WO-2001074783-A1 CYCLIC LACTAMS AS INHIBITORS OF A ΒΕΤΑ PROTEIN PRODUCTION DUPONT PHARMACEUTICALS COMPANY (US) 2001-10-11 WO disclosed